In Compliance with Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018, Jagsonpal Pharmaceuticals forwarded a copy of the Certificate received from MCS Share Transfer Agent, the Registrar and Share Transfer Agent of the Company, for the quarter ended 30th June, 2022.
The above information is a part of company’s filings submitted to BSE.